Creso Pharma Limited carries a market capitalization of 131.72M, placing it among publicly traded companies globally.
| Market Cap | 131.72M |
| Enterprise Value | N/A |
Creso Pharma Limited's stock has gained approximately 2825% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 2825% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.07 |
| Average Volume (20 Days) | N/A |
Creso Pharma Limited's most recent stock split took place on June 4, 2024 with a 30:1 split ratio.
| Last Split Date | 6/4/2024 |
| Split Ratio | 30:1 |